Australian Primary Hemp Ltd (APH) TRADING HALT SUSPENDED

20mins delayed


1 Year Return

Australian Primary Hemp Ltd Chart

Share price
Market Cap $7.39 million
Today's Movement
Prev. Close
Day Range -
Historical Stats
52w Range -
4w Avg Volume
4w Avg Turnover

APH Statistics

07 August

1,887 / 2,230

ASX Size Rank

1yr Return

vs Sector (1yr)


vs ASX 200 (1yr)


$7.39 million

Market Cap

Share Issue

49.24 million

All Ords (%)


Short Sold


Current Fundamentals

07 August


PE Ratio

EPS ($)


Earnings Yield


NTA ($)



Dividend Yield

DPS ($)


Gross Div. Yield


Gross DPS ($)


Company Overview

Australian Primary Hemp Limited (APH, formerly Alchemia Limited) engages in hemp growing and production services as well as handling in all areas of the hemp value chain, encompassing; hemp seed selection, farming, processing, packaging as well as distribution and sale of bulk and retail edible products.APH imports raw FINOLA hemp seeds from Canada and Finland.

Former Names
Alchemia Limited (ACL), 14/10/2019

Australian Primary Hemp Ltd Logo

Corporate Details

Head Office: South Melbourne
Managing Director: Neale Joseph
GICS Sub-Industry: Agricultural Products
Date Listed: 23 Dec 2003
Registry: Link Market Services
Similar Companies: A2M / ELD / UMG / ING / CGC

Upcoming Calendar

Dividend History

Ex-Date Amount Franking Type Payable
01/02/2016 $0.093 0% Interim 24/02/2016

See Upcoming Dividends for all ASX companies.


Date Heading Pages File Size Time

Broker Consensus

The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.

APH is not covered by a major broker,
or data from most recent compilation was omitted due
to not meeting QA guidelines.

Directors & Management

About the Data

Name Title Since Bio
Ms Melanie Jaye Leydin Chief Financial Officer, Company Secretary Apr 2016
Mr Cameron Petricevic Non-Executive Director, Non-Executive Chairman Jun 2018
Ms Pauline Therese Gately Non-Executive Director Oct 2019
Mr James Hood Executive Director, Chief Operating Officer Oct 2019
Mr Michael Sapountzis Joint Company Secretary Mar 2019
Mr Neale Joseph Chief Executive Officer Mar 2020

Director Transactions

About the Data

APH directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
18/11/19 Charles Mann Buy +249,020 $0.201 $50,042 On-market trade.
14/11/19 Charles Mann Buy +657 $0.180 $118 On-market trade.
11/11/19 Charles Mann Buy +4,494 $0.180 $808 On-market trade.
02/10/19 Cameron Petricevic Issued 4,196,500 $0.011 $46,161 Issue of securities.
02/10/19 Cameron Petricevic Issued 1,216,904 $0.011 $13,385 Issue of securities.

Shareholder Distribution

About the Data

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over Total Shareholders
No. of Shareholders 1,454 1,158 481 941 344 4,378

Top 20 Shareholders

About the Data

Name Shares Capital
Shomron Pty Ltd 39,426,777 12.14%
Ttor Pty Ltd 16,069,996 4.95%
HSBC Custody Nominees (Australia) Limited 12,658,835 3.90%
Mr Bilal Ahmad 8,100,000 2.49%
Mr Rick William Langdon 7,936,383 2.44%
Mr Andrew Richard Jackson Ball 7,112,630 2.19%
Mrs Ifrah Nishat 6,313,000 1.94%
California Capital Equity Llc 5,854,719 1.80%
Mr Paul Homewood 5,440,000 1.68%
Mr Jason Brett Randall 5,000,000 1.54%
Mr Brian Riess 5,000,000 1.54%
Mr Sufian Ahmad 4,100,000 1.26%
J P Morgan Nominees Australia Pty Limited 3,937,897 1.21%
Mr Arjunan Sundaramoorthy 3,400,000 1.05%
Maxlen Nominees Pty Ltd 3,394,730 1.05%
Tamborine Trees Pty Ltd 3,000,000 0.92%
Campbell Kitchener Hume & Associates Pty Ltd 2,800,000 0.86%
Dr Robert Julian Hafner 2,573,988 0.79%
Carojon Pty Ltd 2,500,000 0.77%
Mr Garry Webb & Mrs Lorraine Webb 2,500,000 0.77%
All other shareholders 54.71 %

The Top 20 Shareholders of APH hold 45.29% of shares on issue.

APH Share Price History

Date Close Change % Change Open High Low Volume Turnover

APH Historical Data

Download up to 20 years of share price history.

Year Closing Price (30 June) Last Trade

Offical data as published by ASX. See more Data Downloads.

Company Details

Principal Activity: Closure of all Clinical trial activities and efforts to realise value from company owned intellectual property and Review of new opportunities with the aim of providing overall increase to shareholder value.

Incorporated: --

Level 4, 100 Albert Rd
South Melbourne VIC 3205

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.